International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Spironolactone 5-mg/mL in Suspendit Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2018 - Volume 22, Number 2
View All Articles in Issue

Page(s): 152

Spironolactone 5-mg/mL in Suspendit Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Spironolactone 5-mg/mL in Suspendit Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, formulation, spironolactone, potassium-sparing diuretic, antihypertensive agent, hypertension, high blood pressure, edema, liquid dosage form

Related Categories: DERMATOLOGY, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, CARDIOLOGY, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Spironolactone 5-mg/mL in Suspendit Oral Suspension Allen Loyd V Jr	Mar/Apr 2018 Pg. 152
Spironolactone 5 mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Nov/Dec 2017 Pg. 496
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V	Jul/Aug 2017 Pg. 334-338
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	Jul/Aug 2023 Pg. 326
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 183
Stability of Oral Liquid Dosage Forms of Ethacrynic Acid Gupta Vishnu D, Ling Jie	May/Jun 2001 Pg. 232-233
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira	Nov/Dec 2018 Pg. 516-526
Losartan Potassium 2.5-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 248
Chlorothiazide 50-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2014 Pg. 326
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba	Nov/Dec 2022 Pg. 516-521
Stability of an Oral Liquid Dosage Form of Trovafloxacin Mesylate and Its Quantitation in Tablets Using High-Performance Liquid Chromatography Gupta Vishnu D	May/Jun 2000 Pg. 233-235
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 44
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Gupta Vishnu D	Jul/Aug 2008 Pg. 372-374
Return to Top